New study in Clinical Cancer Research

With collaborators in the Oxford Ovarian Cancer Lab and Imperial College London, Zhiyuan Hu has identified that OxC-defined EMT-high SOCs carry particularly poor prognosis independent of established clinical parameters. She found these tumours are associated with high frequency of immunosuppressive macrophages, suggesting a potential therapeutic target to improve clinical outcome.

Christopher Yau
Professor of Artificial Intelligence

I am Professor of Artificial Intelligence. I am interested in statistical machine learning and its applications in the biomedical sciences.